NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000003013

Registered date:01/02/2010

Study investigating the effect of irsogladine maleate on PPI-resistant GERD

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedGERD
Date of first enrollment2010/02/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)co-administration of irsogladine

Outcome(s)

Primary Outcomeclinical symptoms and QOL evaluated by questionaires.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaCases taking H2RA,mucosa defencing agents,mucoprotective agents. Cases who took PPI in the recent 2 weeks. Cases taking NSAIDs,salicylate, antimuscarinic agents,prokinetics, PG. Cases whose inclusion is considered to be inappropriate by the attending physicians.

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail kinosita@med.shimane-u.ac.jp
Affiliation Shimane University Department of Medicine II
scientific contact
Name Yoshikazu Kinoshita
Address 89-1, Enya, Izumo-shi Japan
Telephone
E-mail
Affiliation Shimane University School of Medicine Department of Medicine II